New brief therapy aims to ease anxiety in veterans
NCT ID NCT04829240
First seen Jun 26, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study tested a short, skills-based anxiety treatment for veterans in primary care. 177 veterans with anxiety symptoms were randomly assigned to either the new treatment or usual care. The goal was to see if the brief therapy reduces anxiety and improves daily functioning better than standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Veterans Anxiety Skills Training (VAST) - a brief behavioral intervention
- What this could lead to
- If it works, this could provide an effective, short-term therapy option for veterans with anxiety in primary care settings.
- What could go wrong
- This is a relatively small, completed trial. The intervention may not prove more effective than usual care, and results may not apply to all veterans or non-veteran populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
213 people
The number who actually took part.
- Started
-
Aug 2021
- Finished
-
Aug 2025
- Lead sponsor
-
A government agency
The lead sponsor is a US federal agency other than the NIH.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Patient Inclusion Criteria: * Veteran, * Age \>=18 years, * Seen in the Syracuse or Western New York VAMC or CBOC primary care clinic in the past 12 months, * Screen positive for current (past 2 weeks) clinically significant anxiety symptoms (\>= 8 on GAD7) Provider Inclusion Criteria: * Current behavioral health provider working in Primary Care-Mental Health Integration (PCMHI) at the VA Syracuse or VA Western New York healthcare system, including full-time, part-time, and trainee status Patient Exclusion Criteria: * Inability to communicate in English (as assessed by study staff); * Hearing impairment that precludes completion of telephone eligibility screening (as assessed by study staff); * Cognitive impairment that precludes informed consent, defined as any of the following: * not able to comprehend the study description or eligibility screening as assessed by study staff, * diagnosis of dementia or severe cognitive impairment per self-report, primary care provider, or Problem List, or * screen positive for cognitive impairment (\>= 3 errors on screener); * Diagnosis of Obsessive-Compulsive Disorder (OCD) or serious mental illness (SMI, i.e., psychotic disorders, bipolar disorder) in Problem List; * Encounter diagnosis of Posttraumatic Stress Disorder (PTSD) within the past 2 years or screen positive for PTSD (\>= 4 for men or \>= 5 for women on the Primary Care PTSD Screen for DSM-5; * Currently in psychotherapy/counseling for anxiety and/or depression, defined as any of the following within the past 30 days: * attending \>= 1 non-intake specialty mental health session, * attending \>= 2 PCMHI sessions, or * being hospitalized for mental health treatment; * Current (past 2 weeks) severe depressive symptoms (\>= 20 on PHQ9); * At imminent risk of suicide, defined as being in need of intensive treatment (e.g., hospitalization) to ensure safety, based on study staff's suicide risk assessment (verified by the PI); * Started or had dosage change in psychotropic medication for anxiety or depression in the past 30 days Provider Exclusion Criteria: * None
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, 13210-2716, United States
-
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, 14215-1129, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- VR headset may calm kids before heart procedure
- Could a whiff of xenon replace the Pre-Surgery chill pill?
- Can a pencil and paper calm anxious teens with diabetes?
- Can a tailored therapy ease anxiety and depression in autistic teens?
- Leg cuffs plus walking: a new way to steady Parkinson's balance?